Atara Biotherapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.09

-0.42 (-4.94%)

As of Aug 15, 2:27 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 2 20%

Sell 1 10%

Price Target

Analyst Price Target -13.0% upside

Low Target $5.84

Average Target $7.04

High Target $9.41

Current Price $8.09

Current
$8.09

Target
$7.04

$5.84 $7.04 avg $9.41

Scenario Analysis

Bear Case

$5.84

-27.8%

Low target

Base Case

$7.04

-13.0%

Avg target

Bull Case

$9.41

+16.3%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$19.15

-57.7% from high

52-Week Low

$3.92

+106.4% from low

Target vs 52W High

$7.04

-63.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%